{
    "2018-03-28": [
        [
            {
                "time": "2018-03-28",
                "original_text": "周四机构一致最看好6只个股（3.28）",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "年报点评",
                        "Q4业绩回暖",
                        "血制品营销改革"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "明日之星：布局新经济领域机会",
                "features": {
                    "keywords": [
                        "新经济",
                        "布局机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "东北证券：上调华兰生物评级至买入",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "评级上调",
                        "买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[审慎增持评级]华兰生物(002007)年报点评：血制品业务保持平稳增长 营销建设加强值得期待",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品业务",
                        "营销建设"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]华兰生物(002007)点评：静待业绩不断改善",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "业绩改善"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]流感疫苗行业专题：四价流感疫苗获批在即 空间广阔",
                "features": {
                    "keywords": [
                        "流感疫苗",
                        "四价流感疫苗",
                        "获批在即"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物一疫苗产品获生产批件",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "疫苗产品",
                        "生产批件"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物:Q4业绩明显改善,四价流感疫苗获批在即",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "Q4业绩",
                        "四价流感疫苗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}